Meta-analysis of In-stent Restenosis Factors after Coronary Intervention
Journal: Journal of Clinical Medicine Research DOI: 10.32629/jcmr.v5i2.2324
Abstract
This aim is to explore the relevant factors affecting in-stent restenosis after coronary intervention procedures. Relevant research literature was searched through domestic and international databases and Meta-analysis was performed. Smoking, alcohol consumption, hypertension, hyperlipidemia, diabetes mellitus, low-density lipoprotein cholesterol, total cholesterol, triglycerides, uric acid level, number of implanted stents, and stent length were significantly associated with in-stent restenosis (P<0.05). Factors such as gender, age, body mass index, high-density lipoprotein cholesterol, and left ventricular ejection fraction were not significantly correlated with in-stent restenosis (P>0.05).
Keywords
coronary heart disease; in-stent; restenosis
Full Text
PDF - Viewed/Downloaded: 2 TimesReferences
[1] Banning AP, Baumbach A, Blackman D, et al. Percutaneous coronary intervention in the UK: recommendations for good practice 2015[J]. Heart,2015,101(Suppl 3)1-13.
[2] Kasaoka S, Tobis JM, Akiyama T, et al. Angiographic and intravascular ultrasound predictors of in-stent restenosis[J]. Journal of the American College of Cardiology,1998,32(6):1630-1635.
[3] Kereiakes DJ, Midei M, Hermiller J, et al. Procedural and late outcomes following MULTI-LINK
DUET coronary stent deployment[J]. American Journal of Cardiology,1999,84(12):1385-1390.
[4] Houezec JL, Benowitz NL. Basic and clinical psychopharmacology of nicotine[J]. Clinics in Chest Medicine,1991,12(4):681-699.
[5] Nishio K, Fukui T, Tsunoda F, et al. Insulin resistance as a predictor for restenosis after coronary stenting[J]. International Journal of Cardiology,2005,103(2):128-134.
[6] Jang JY, Kim JS, Shin DH, et al. Favorable effect of optimal lipid-lowering therapy on neointimal tissue characteristics after drug-eluting stent implantation: Qualitative optical coherence tomographic analysis[J]. Atheros clerosis,2015,242(2):553-559.
[7] Muller JE, Tofler GH, Stone PH. Circulation variation and triggers of onset of acute cardiovascular disease[J]. Circulation,1989,79(4):733-743.
[8] Cutlip DE,Windecker S,Mehran R,et al.Clinical end points in coronary stent trials: a case for standardized definitions[J].Circulation,2007,115(17): 2344-2351.
[9] Jukema JW,Verschuren JJ,Ahmed TA,et al.Restenosis after PCI.Part 1: patho physiology and risk factors[J].Nat Rev Cardiol,2012,9(1): 53-62.
[10] Wang, P., Qiao, H.,Wang, R.etal. The characteristics and risk factors of in-stent restenosis in patients with percutaneous coronary intervention: what can we do. BMC Cardiovasc Disord 20, 510 (2020). https://doi.org/10.1186/s12872-020-01798-2
[2] Kasaoka S, Tobis JM, Akiyama T, et al. Angiographic and intravascular ultrasound predictors of in-stent restenosis[J]. Journal of the American College of Cardiology,1998,32(6):1630-1635.
[3] Kereiakes DJ, Midei M, Hermiller J, et al. Procedural and late outcomes following MULTI-LINK
DUET coronary stent deployment[J]. American Journal of Cardiology,1999,84(12):1385-1390.
[4] Houezec JL, Benowitz NL. Basic and clinical psychopharmacology of nicotine[J]. Clinics in Chest Medicine,1991,12(4):681-699.
[5] Nishio K, Fukui T, Tsunoda F, et al. Insulin resistance as a predictor for restenosis after coronary stenting[J]. International Journal of Cardiology,2005,103(2):128-134.
[6] Jang JY, Kim JS, Shin DH, et al. Favorable effect of optimal lipid-lowering therapy on neointimal tissue characteristics after drug-eluting stent implantation: Qualitative optical coherence tomographic analysis[J]. Atheros clerosis,2015,242(2):553-559.
[7] Muller JE, Tofler GH, Stone PH. Circulation variation and triggers of onset of acute cardiovascular disease[J]. Circulation,1989,79(4):733-743.
[8] Cutlip DE,Windecker S,Mehran R,et al.Clinical end points in coronary stent trials: a case for standardized definitions[J].Circulation,2007,115(17): 2344-2351.
[9] Jukema JW,Verschuren JJ,Ahmed TA,et al.Restenosis after PCI.Part 1: patho physiology and risk factors[J].Nat Rev Cardiol,2012,9(1): 53-62.
[10] Wang, P., Qiao, H.,Wang, R.etal. The characteristics and risk factors of in-stent restenosis in patients with percutaneous coronary intervention: what can we do. BMC Cardiovasc Disord 20, 510 (2020). https://doi.org/10.1186/s12872-020-01798-2
Copyright © 2024 Liqing Gao, Hengjin Dong
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License